Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Metformin, an Activator of AMPK, on Cognitive Measures of Progression in Huntington's Disease Patients Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Metformin, an Activator o ...